Letrozole
11 NDCs across 7 manufacturers|10 Generic,1 Brand
Letrozole is used to treat breast neoplasms, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jul 25, 1997, and the first generic was approved Dec 24, 2008. FDA's Orange Book lists 6 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $21 million on Letrozole across 862,000 claims for 214,000 beneficiaries.
Letrozole is available as 11 NDCs from 7 manufacturers (10 generic, 1 brand), with NADAC prices from $0.15 to $27.12 per EA — the most expensive product costs about 179× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
11
10G / 1B
Manufacturers
7
competing in market
Price Spread
$0.15 – $27.12
per EA
7d Activity
avg +0.8% WoW · of 11 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
7 manufacturers producing LETROZOLE(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
FEMARA 2.5 MG TABLET | $27.1160 per EA | — |
LETROZOLE 2.5 MG TABLET | $0.1511 per EA | +0.77% |
LETROZOLE 2.5 MG TABLET | $0.1511 per EA | +0.77% |
LETROZOLE 2.5 MG TABLET | $0.1511 per EA | +0.77% |
LETROZOLE 2.5 MG TABLET | $0.1511 per EA | +0.77% |
LETROZOLE 2.5 MG TABLET | $0.1511 per EA | +0.77% |
LETROZOLE 2.5 MG TABLET | $0.1511 per EA | +0.77% |
LETROZOLE 2.5 MG TABLET | $0.1511 per EA | +0.77% |
LETROZOLE 2.5 MG TABLET | $0.1511 per EA | +0.77% |
LETROZOLE 2.5 MG TABLET | $0.1511 per EA | +0.77% |
LETROZOLE 2.5 MG TABLET | $0.1511 per EA | +0.77% |
Frequently Asked Questions
What is Letrozole used to treat?
Letrozole is used to treat breast neoplasms, per the National Library of Medicine's MED-RT classification.
When did Letrozole become available as a generic?
FDA approved the first generic Letrozole (ANDA) on Dec 24, 2008. The Orange Book currently lists 6 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Letrozole?
In 2024, Medicare Part D spent $21 million on Letrozole across 862,000 claims for 214,000 beneficiaries.
How many Letrozole products are on the market?
The Letrozole drug market contains 11 NDCs from 7 manufacturers — 10 generic and 1 brand product.
What is the price range for Letrozole?
NADAC reference prices for Letrozole range from $0.1511 to $27.1160 per EA — the most expensive product costs about 179× the cheapest.
Is generic Letrozole cheaper than brand?
The average generic NADAC for Letrozole is $0.1511 per EA, versus $27.1160 for brand-labeled products — brand versions average about 179× the generic price.
Which manufacturers make Letrozole?
7 manufacturers list Letrozole in NADAC. Ranked by number of NDCs, the largest are Breckenridge Pharmaceutical Inc. (3), Accord Healthcare Inc. (2), Chartwell RX LLC (2), Novartis Pharmaceuticals Corporation (1), AvPAK (1).
How has the price of Letrozole changed recently?
Over the past 7 days, 10 Letrozole NDCs rose and 0 fell, with a market-wide average change of +0.8%.